Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients with advanced melanoma (MEL) (CheckMate 067) Meeting Abstract
| Authors: | Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Wagstaff, J.; Hogg, D.; Hill, A.; Carlino, M. S.; Wolter, P.; Lebbé, C.; Schachter, J.; Thomas, L.; Hassel, J. C.; Lorigan, P.; Walker, D.; Jiang, J.; Hodi, F. S.; Wolchok, J. D. |
| Abstract Title: | Efficacy and safety in key patient subgroups of nivolumab (NIVO) alone or combined with ipilimumab (IPI) versus IPI alone in treatment-naive patients with advanced melanoma (MEL) (CheckMate 067) |
| Meeting Title: | 18th European Cancer Conference (ECCO 18) |
| Journal Title: | European Journal of Cancer |
| Volume: | 51 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2015 Sep 25-29 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S664 |
| End Page: | S665 |
| Language: | English |
| ACCESSION: | WOS:000361887403141 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(16)31822-6 |
| Notes: | Meeting Abstract: 3303 -- Source: Wos |
